Category Archive for: ‘Drug Trials’

FDA Approves New Drug to Alleviate Moderate to Severe Pain

FDA NewsNovember 24, 2008 The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100 mg. “This approval offers health care professionals an additional choice for treating moderate to severe …

Read More

Clinical Trial, New Medication – Tapentadol

Treating Pain Effectively – New Study Results Confirm Improved Gastrointestinal Tolerability Of Tapentadol Medical News Today, Article Date: 15 Jun 2008 – 2:00 PDT Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal tolerability(1) as well as safety(2) profile compared to oxycodone HCl IR. More…

Read More